DHI vs IBO · P/E 9.6, rev $34.25B vs rev $10.0K
DR Horton Inc (DHI) versus Impact BioMedical, Inc. (IBO) — a side-by-side from cached financials, not a winner call.
DR Horton Inc (DHI) is a residential construction company listed on US.
Impact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
Latest reported DHI revenue for 2025-09-30 was $34.25B. Net income was $3.62B. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
Latest reported IBO revenue for 2026-06-30 was $10.0K. Net income was -$3.0M. Revenue was up 42.9% from 2026-03-31 to 2026-06-30. IBO currently screens at market cap $7.6M.
DHI currently screens at market cap $39.10B and trailing P/E 9.6. IBO currently screens at market cap $7.6M.
Not investment advice. Open the DHI and IBO stock pages for the full models.
Not investment advice.